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O B J E C T I V E S This study sought to identify possible anatomic predictors of acute type B aortic
dissection (AAD) in hypertensive patients using multidetector computed tomography angiography
(CTA).
B A C KG ROUND Although hypertension remains one of the most signiﬁcant risk factors for AAD
development, it is unlikely to be the only risk factor for AAD. Few studies have assessed anatomical
predictors of AAD development.
METHOD S CTA of normotensive patients without AAD (group 1, n  35), hypertensive patients
without AAD (group 2, n  37), and hypertensive patients with AAD (group 3, n  37) were compared.
The length, diameter, volume, and tortuosity of the aorta as well as arch vessel angulation were
measured for each patient and normalized to group 1 averages. Stepwise logistic regression identiﬁed
signiﬁcant anatomical associations; the model was validated based on 1,000 bootstrapped samples.
R E S U L T S The demographics of the groups were similar. The length of the proximal and entire aorta,
the diameters in the proximal ascending aorta and aortic arch, and the aortic volumes were all greater
(p  0.0001, p  0.0064 for ascending aortic diameter) in group 3 than in groups 1 and 2, as was entire
aortic tortuosity (p  0.0001). An AAD risk model was developed based on aortic arch diameter, length
from the aortic root to the iliac bifurcation, and angulation of the brachiocephalic artery origin from the
aorta. The bootstrap estimate of the area under the receiver operating curve was 0.974.
CONC L U S I O N S Enlargement of the ascending aorta and aortic arch and increased aortic
tortuosity reﬂect an aortopathy which enhances the probability of AAD. A model based on 3 anatomical
variables demonstrates signiﬁcant associations with AAD: it may allow identiﬁcation by aortic imaging
of the hypertensive patient most at risk, and permit implementation of aggressive medical management
and consideration of pre-emptive surgery to prevent dissection. (J Am Coll Cardiol Img 2013;6:349–57)
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350cute type B aortic dissection (AAD) is a
highly feared thoracic aortic pathology en-
countered in hospital settings. Although
many type B AADs can be managed
medically, most patients with this pathology suffer
significant morbidity and mortality (1). Even after
optimal medical and surgical therapy, the long-
term prognosis of type B AAD is dismal, with 5-
and 10-year survival rates of 60% and 35%,
respectivley (2,3).
Hypertension remains one of the most significant
risk factors for type B AAD development, with
nearly 75% of patients having a history of hyper-
tension (4). Nevertheless, although nearly 75 mil-
lion adults in the United States are hypertensive,
the incidence of AAD is only 2.9 to 3.5 per 100,000
person-years (5,6). Given the high mortality rate
and dismal long-term prognosis of type B AAD, it
seems logical to try to identify additional character-
istics that might predispose an individual with
hypertension to development of type B AAD. This
study is an attempt to provide an anatomic aortic
profile to identify those hypertensive patients most
at risk, who may need more aggressive
medical management or even pre-emptive
surgery to prevent dissection.
M E T H O D S
Study design. A review of our institutional
database disclosed 56 patients with AAD
who presented to Mount Sinai Medical Center
(MSMC) from February 2002 to July 2010. A
multidetector computed tomography angiography
(CTA) within 2 weeks of presentation and symp-
tom onset was required to diagnose AAD: patients
with type B AAD were excluded from the study if
CTA was not carried out as part of the diagnostic
examination, if the study was done at an outside
institution, if the dissection was secondary to a
traumatic event, or evidence of congenital or con-
nective tissue disease was found, such as bicuspid
aortic valve or Marfan’s syndrome. These criteria
resulted in inclusion of 37 type B AAD patients.
Data from these patients were compared with those
for 37 hypertensive patients without AAD and
those for 35 normotensive patients without AAD
who underwent CTA.
The institutional review board approved this
retrospective research and waived the need for
individual patient consent. Patient information was
obtained from medical records of patients present-
n
ted
rveing to the MSMC Emergency Department (ED)with AAD or who were transferred to our institu-
tion after confirmation of diagnosis. Normotensive
and hypertensive adult patients who presented to
the ED with episodes of chest, abdominal, or back
pain described as sharp, pressure-like, or aching and
who underwent CTA to determine the cause of the
presenting symptoms were included in the study.
ED medical records of these patients were then
assessed for patients’ presenting blood pressure and
antihypertensive medication history.
Computed tomography. Electrocardiographic
ECG)-gated CTA of the thoracic aorta was car-
ied out with injection of 100 ml of contrast with 50
l of saline chaser, threshold 80 HU; rotation
peed: 330 ms; collimation: 64  0.6 mm; pitch:
.2; voltage: 140 kV; current: 700 to 850 mAs.
atasets were analyzed on a cardiovascular worksta-
ion (AquariusWS version 3.7.0.13, TeraRecon, San
ateo, California) using dedicated vascular analysis
oftware. The software enables real-time diagnostic
eview of 2-, 3-, and 4-dimensional images for man-
ging large thin-slice computed tomography and
agnetic resonance scans, and includes workflow
ools which simplify the interpretation by automati-
ally presenting the 3-dimensional volume based on
he study type selected by the operator.
The length of the ascending aorta from the aortic
oot to the left subclavian artery, and the entire
orta from the aortic root to the iliac bifurcation
ere measured (Fig. 1). Additional measurements
ncluded the volumes of the ascending aorta and the
ortic arch, as well as the maximal diameters of the
ortic root, the ascending aorta at the right pulmo-
ary artery, and the aortic arch. Tortuosity of the
orta, defined as the length of the midline within
he aorta divided by the linear distance between the
ortic root and the iliac bifurcation, was also calcu-
ated. The tortuosity of the ascending aorta, defined
s the measured length of the ascending aorta
ivided by the linear distance between the aortic
oot and left subclavian artery, was similarly calcu-
ated for each patient (Figs. 2A and 2B). The angle
f the origin of the brachiocephalic and of the left
ubclavian arteries from the aortic arch was mea-
ured. The volume and diameter measurements of
he descending and abdominal aorta were likely
onfounded by the presence of type B AAD, and
ere not compared between the groups. Analysis
as therefore restricted to the ascending aorta and
ortic arch proximal to the left subclavian artery.
Statistical analysis. For group comparisons, we used
chi-square tests or Fisher exact tests for categoricalA B B R E V I A T I O N S
A N D A C R O N YM S
AAD acute aortic dissectio
CTAmultidetector compu
tomography angiographyvariables, analysis of variance (ANOVA) allowing
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 6 , N O . 3 , 2 0 1 3
M A R C H 2 0 1 3 : 3 4 9 – 5 7
Shirali et al.
Anatomic Predictors and AAD
351for heterogeneous group variances using PROC
MIXED in SAS version 9.2 software (SAS Insti-
tute Inc., Cary, North Carolina), or nonparametric
Kruskal-Wallis tests for continuous variables. For
Figure 1. Aortic Length Measurement
Volume-rendering multidetector computed tomography angiograph
measurement of the (A) proximal aorta and (B) entire aorta.
Figure 2. Aortic Tortuosity Measurement
Volume-rendering CTA of a type B AAD patient with tortuosity mea
as in Figure 1.pairwise comparisons in Tables 1 and 2, we were
interested in comparing the hypertensive group
against normotensive and AAD groups. We have
reported the individual pairwise p values. One may
TA) of a type B acute aortic dissection (AAD) patient with length
ment of the (A) proximal aorta and (B) entire aorta. Abbreviationsy (Csure
r
f
o
i
e
s
u
d
ANOVA  analysis of var
AAD  acute aortic disse
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352exercise judgment to correct for multiple compari-
sons by multiplying the p values by the number of
comparisons (e.g., 2). For most pairwise compari-
sons, the conclusions are the same with or without
adjustment of multiple comparisons. The correlation
between ascending aortic volume and diameter and
systolic blood pressure was evaluated by Pearson cor-
relation coefficient. Stepwise logistic regression analy-
ses were performed to identify significant predictors of
AAD. The covariates considered in the initial model
included measurements of diameter, length, tortuos-
ity, and angulation listed in Table 3. Results were
eported as odds ratios and 95% confidence intervals
or the identified risk factors.
We used the bootstrap method to validate the
model selection (7). For each sample the same step-
wise model selection procedure was used with entry
and stay criteria set to be 0.1, leading to potentially
different selection of significant AAD anatomic vari-
cs of Study Groups
Group 1
(n  35)
Group 2
(n  37)
Group 3
(n  37
16 (46) 24 (65) 24 (65)
53.00 17.54 60.00 16.27 60.00 1
2 27.57 6.52 30.06 5.34 29.00 5
125.83 13.13 138.78 28.48 155.08 2
73.14 10.89 80.38 16.97 82.81 2
 SD. Group 1  normotensive; group 2  hypertensive; group 3  type B acu
iance.
ariables of Normotensive, Hypertensive, and AAD Patients Scale
Group 1 Group 2 Group
100.00 11.24 101.42 8.97 120.34
n 100.00 15.49 100.82 13.56 116.89
100.00 30.35 122.59 36.45 174.56
100.00 34.15 110.16 27.09 167.26
n 100.00 6.78 100.97 9.86 100.69
n 100.00 11.80 102.33 12.52 113.87
100.00 25.92 86.10 23.84 79.83
100.00 20.22 97.67 15.92 92.91
100.00 14.90 104.84 10.84 121.20
PA 100.00 14.57 113.44 13.43 123.48
100.00 15.04 103.75 12.04 138.61
1  normotensive (n  35); group 2  hypertensive (n  37); group 3  type
ction; AR  aortic root; RPA  right pulmonary artery; STJ  sinotubular junction; oables. The procedure robustness was evaluated by the
consistency of the selected covariates. The bootstrap
estimate of the coefficient for AAD was then com-
pared to that from the model using all the data. The
model’s strength selected by this procedure was as-
sessed by the area under the receiver-operating curve
(ROC) by using the nonparametric “0.632” estimate
value. This estimate uses a weighting of 0.368 
apparent  0.632  average (test) to correct for
veroptimism in the sample estimate, where apparent
s the estimate from the entire dataset, and test is the
stimate from patients not selected in the bootstrap
ample (8,9). All statistical analyses were carried out
sing SAS version 9.2 (SAS Institute, Inc.).
R E S U L T S
Anatomical variables. The patient groups showed no
ifference in age, sex, or body mass index (Table 1).
ANOVA
p Value
Groups 1 vs. 2
p Value
Groups 2 vs. 3
p Value
0.17 — —
0.01 — —
0.32 — —
0.0001 0.01 0.02
0.01 0.03 0.58
rtic dissection.
o Normotensive Mean Values
ANOVA
p Value
Groups 1 vs. 2
p Value
Groups 2 vs. 3
p Value
1 0.0001 0.81 0.0001
6 0.0001 0.56 0.0001
5 0.0001 0.0068 0.0001
7 0.0001 0.083 0.0001
0.87  
2 0.0001 0.42 0.0001
5 0.0011 0.02 0.21
9 0.18 0.59 0.18
7 0.0001 0.13 0.0001
8 0.0001 0.0001 0.0064
0 0.0001 0.25 0.0001
D (n  37).Table 1. Characteristi
)
Male
Age, yrs 2.21
Body mass index, kg/m .96
Blood Pressure
Systolic 8.68
Diastolic 0.22
Values are n (%) or mean te aoTable 2. Anatomical V d T
3
Length
AR to left subclavian 12.1
AR to iliac bifurcatio 14.3
Volume
Ascending aorta 53.6
Aortic arch 56.7
Tortuosity
STJ to left subclavia 8.81
STJ to iliac bifurcatio 11.4
Head vessel angle
Brachiocephalic 18.1
Left subclavian 14.3
Diameter
AR 16.5
Ascending aorta at R 17.3
Aortic arch 31.8
Values are %  SD. Group B AA
ther abbreviation as in Table 1.
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353Table 3 summarizes the normotensive patient ana-
tomical data. Compared with normotensive pa-
tients, the lengths of the proximal and entire aorta
were 101% and 101% in hypertensive patients
without AAD and 117% and 120% in patients with
AAD (Table 2). The proximal and entire aortic
lengths were significantly larger in AAD patients
compared with both normotensive and hypertensive
patients (p  0.0001), but statistically insignificant
between hypertensive and normotensive patients
without AAD.
Volumetric analysis showed significant differ-
ences among the 3 groups in the ascending aorta
and aortic arch (p  0.0001). The volumes of the
ascending aorta and aortic arch in hypertensive
patients were 123% and 110% those of normoten-
sive patients. The volumes in AAD patients were
175% and 167% those of normotensive patients
(Table 2). Both the ascending aortic and aortic arch
volumes were significantly larger in AAD patients
than in either normotensive or hypertensive patients
(p  0.0001), and hypertensive patients had signifi-
antly larger ascending aortic volumes than normo-
ensive patients (p  0.0068). The correlation coeffi-
cient for the relationship between ascending aortic
volume and systolic blood pressure is 0.33 (p 
0.0005), suggesting a positive relationship between
systolic blood pressure and ascending aortic volume.
Diameter analysis similarly showed significant
differences among the 3 groups at the aortic root,
ascending aorta (at right pulmonary artery), and
Table 3. Anatomical Variables of Normotensive Patients
Group 1
Length, mm
AR to left subclavian 105.68 16.37
AR to iliac bifurcation 453.93 51.02
Volume, ml
Ascending aorta 72.51 22.01
Aortic arch 20.23 6.91
Tortuosity
STJ to left subclavian 1.33 0.09
STJ to iliac bifurcation 1.86 0.22
Head vessel angle, °
Brachiocephalic 57.09 14.80
Left subclavian 79.97 16.17
Diameter, cm
AR 3.01 0.45
Ascending aorta at RPA 3.07 0.45
Aortic arch 2.60 0.39
Values are mean  SD. Group 1  normotensive (n  35).
Abbreviations as in Table 2.aortic arch (p 0.0001). The aortic root, ascendingaorta, and aortic arch diameters of hypertensive
patients were 105%, 113%, and 104% those of
normotensive patients. The maximal diameters of
AAD patients at these 3 locations were 121%,
124%, and 139% compared to those of normoten-
sive patients (Table 2). The aortic root, ascending
aortic and aortic arch diameters were all signifi-
cantly larger in AAD patients compared with both
normotensive and hypertensive patients (p 
0.0001, p  0.0064 for ascending aorta). The
difference in aortic diameters between hypertensive
and normotensive patients was statistically insignif-
icant except at the ascending aorta (p  0.0001).
The correlation coefficient associated with the rela-
tionship between ascending aortic diameter and
systolic blood pressure is 0.31 (p  0.0012), sug-
gesting a positive relationship between ascending
aortic diameter and systolic blood pressure.
No significant differences between groups were
observed in the tortuosity of the proximal aorta or
in the left subclavian artery angle. There was,
however, a significant difference between the 3
groups in tortuosity of the entire aorta (p 
0.0001): tortuosity in hypertensive patients was
102%, and in AAD patients 114% that of normo-
tensive patients (Table 2). Tortuosity of the entire
aorta was significantly greater in AAD patients than
in normotensive and hypertensive patients (p 
0.0001), but statistically insignificant between hy-
pertensive and normotensive patients. In addition,
there was a significant difference between the three
groups in the brachiocephalic artery angle (p 
0.0011) with angulation of 86% in hypertensive
patients and 80% in AAD patients. Brachiocephalic
artery angulation was significantly lower in hyper-
tensive patients than in normotensive patients (p 
0.02), but insignificant between hypertensive and
AAD patients.
Risk model using anatomic variables. A multivariable
odel was developed to provide a means by which
ne might find aortic anatomic variables with
trong association to AAD occurrence. Stepwise
ogistic regression identified aortic arch diameter,
ntire aortic length, and the brachiocephalic artery
ngle as variables with strong association, scaled by
he means of the normotensive group presented in
able 3 and then multiplied by 100.
Table 4 illustrates multivariable models and
odel validation. The probability (Pr) of AAD is
r(AAD)  e y1  e y, in which e refers to the
natural exponential function and y is the linear
combination of the values of the variables (relative
to the normotensive group and multiplied by 100)
rtic d
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354multiplied by the  coefficients listed in Table 4.
The equation in Model 1 based on the stepwise
selection has strong predictability (area under the
ROC). The increment in predictive power is from
0.909 (if only the diameter was used as the predic-
tor) to 0.962 if length was also added, and 0.974 if
brachiocephalic angle was included last. Model selec-
tion using stepwise logistic regression was repeated for
1,000 bootstrapped samples, leading to a potentially
different selection of significant AAD anatomic vari-
ables. Aortic arch diameter appeared in at least 99% of
the repetitions, followed by aortic length (81%), aortic
tortuosity (56%), and brachiocephalic angle (48%). No
other anatomic variables listed in Table 3 appeared
more than 40% of the time. There was a slight
improvement in ROC if the model included aortic
tortuosity as an additional variable (area under ROC:
0.977). Therefore, validation using bootstrap method-
ology showed a high degree of consistency among the
covariates included in Model 1.
Blood pressure and antihypertensive medication.
Table 1 summarizes the systolic and diastolic blood
pressures in the three patient groups. As expected,
the groups had different systolic and diastolic blood
pressures (p  0.0001 and p  0.01, respectively).
Systolic pressures were significantly higher in AAD
patients compared with both normotensive and
hypertensive patients (p  0.02) but the extent to
which they were higher than in the hypertensive
group was less than might have been anticipated
perhaps because some of the patients had antihy-
pertensive treatment, usually intravenous labetalol
or clonidine, prior to admission to our institution.
Table 5 lists the differences in hypertension
management between patients with AAD and hy-
pertensive patients without AAD. Normotensive
patients by definition were not on antihypertensive
medications. Among AAD patients, 32 of 37 (87%)
Table 4. Multivariable Model and Model Validation for Pr(AAD)
Model # Predictor -Coefﬁcient Standard E
1 Intercept 31.9842 7.6473
Diameter: aortic arch 0.1264 0.0322
Length: AR to iliac BF 0.2000 0.0606
HVA: brachiocephalic 0.0646 0.0241
2 Intercept 37.0643 8.9600
Diameter: aortic arch 0.1254 0.0333
Length: AR to iliac BF 0.1900 0.0621
Tortuosity: STJ to iliac BF 0.0518 0.0359
HVA: brachiocephalic 0.0558 0.0252
BF  bifurcation; HVA  head vessel angle; Pr(AAD)  probability of acute aowere taking antihypertensive medications, while 26 of37 (70%) hypertensive patients without AAD were
taking antihypertensive medications: this difference
was insignificant. Despite the somewhat higher blood
pressures recorded in AAD patients, no difference was
found in the number of antihypertensive medications
being taken between the 2 groups.
D I S C U S S I O N
The present study devised an aortic profile based on
retrospective CTA analysis that paves the pathway
for predicting AAD occurrence. CTA imaging
provides excellent diagnostic accuracy for AAD
(between 88% and 100%) and allows the full extent
of the acute dissection to be visualized noninva-
sively (10). Using the IRAD (International Registry
of Aortic Dissection) database, Moore et al. (11)
found that CTA has a sensitivity of 93% for
diagnosing type B AAD: it is currently the most
frequently used imaging modality for diagnosing
AAD and most often the initial test to be done
when AAD is suspected.
Few studies have explored the use of CTA to
provide measurements that may be used for preven-
tion of dissection, however. Mathematical models
diction
Odds Ratio
95% Conﬁdence
Interval p Value
Predictability
(Area Under ROC)
0.0001 0.974
1.135 1.065, 1.209 0.0001
1.211 1.085,1.375 0.001
0.937 0.894, 0.983 0.0072
0.0001 0.977
1.134 1.062, 1.210 0.0002
1.209 1.071, 1.366 0.0022
1.053 0.982, 1.130 0.15
0.946 0.900, 0.994 0.03
issection; ROC  receiver-operating curve; other abbreviations as in Table 2.
Table 5. Comparison of Antihypertensive Medication Number
Between Hypertensive and AAD Patients
Group 2
(n  37)
Group 3
(n  37) p Value
HTN meds 26 (70) 32 (87) 0.09
0 HTN meds (n  16) 11 (30) 5 (14)
1 HTN med (n  19) 8 (22) 11 (30)
2 HTN meds (n  19) 9 (24) 10 (27) 0.55
3 HTN meds (n  14) 6 (16) 8 (22)
3 HTN meds 3 (8) 3 (8)
Values are n (%). Group 2  hypertensive; group 3  type B AAD.Pre
rrorAAD  acute aortic dissection; HTN  antihypertensive.
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355to predict type A AAD development have been
constructed (12), but few studies have found con-
clusive anatomic evidence to predict type B AAD.
Using the IRAD database, Pape et al. (13) found
that ascending aortic diameter 5.5 cm could not
adequately predict risk of type A AAD. The data-
base was further used to retrospectively assess type
B AAD risk, which found that descending aortic
diameter 5.5 cm could not predict type B AAD,
with over 80% of patients with diameters 5.5 cm
developing dissection (14). Both studies concluded
that aortic diameter measurements are not useful
parameters for prevention of AAD, yet both retro-
spectively measured aortic segments within the
dissected area, decreasing the utility and reliability
of the measurements. The current study, however,
uses anatomic variables proximal to the dissection area
to associate with type B AAD risk and few measure-
ments of aortic segments distal to the left subclavian
artery were used because they are likely distorted by
the presence of dissection and are therefore useless
when considering prediction. In considering the aorta
proximal to the left subclavian artery, we found that
both volume and diameter of the ascending aorta are
increased in hypertensive patients without AAD, and
further increased in AAD patients, who also present
with significantly higher systolic blood pressures.
These findings conform to current literature, which
demonstrates that ascending aortic enlargement is
common among patients presenting with type B
AAD. In a large retrospective study, Booher et al. (15)
find that over 40% of type B AAD patients had a
proximal aorta that measured 4.0 cm and suggest
hat the proximal aortic dilatation may be a marker of
he diffuse nature of aortic disease. We go on to find
positive correlation between the volume and diam-
ter of the ascending aorta and systolic blood pressure,
uggesting that the proximal aorta may not only serve
s a potential marker for aortic disease, but also as one
or poorly controlled hypertension. Although the use
f ascending aortic diameter as a marker for poorly
ontrolled hypertension is tempting due to the ease with
hich it may be measured via echocardiography, further
nvestigation with a larger sample size is warranted before
pecific recommendations can be given.
The lack of association between aortic diameter
t the dissection site and AAD development sug-
est that the search for measures of AAD risk must
o beyond conventional measures of aortic diame-
er. We find that the increased length of the
scending aorta in AAD patients compared with
ormotensive and hypertensive patients, and theack of a difference in this length between hyper- aensive and normotensive patients, provides a
trong association that warrants prospective testing
o determine its utility as a predictor of AAD risk.
ncreased length of the ascending aorta in the
etting of hypertension may induce disturbed or
urbulent blood flow. Studies using computed to-
ography imaging to measure blood flow in pa-
ients with type B AAD have shown areas of highly
isturbed and turbulent flow with high values of
all sheer stress around the area of the true lumen
16). In the setting of an already dilated proximal
orta, the increased length may serve to further
isturb blood flow in the hypertensive patient and
ncrease the chance of dissection.
We further provide a multivariable model using
ortic arch diameter, entire aortic length, and bra-
hiocephalic artery angle to assess their association
ith AAD development in hypertensive patients.
iterature centered on type B AAD prediction has
outinely cited the inability of one risk factor,
amely aortic diameter, to predict dissection develop-
ent. With this model, we provide the first attempt to
ombine several easily obtainable anatomic variables to
ssess AAD risk. This model has a predictability of
.974 after internal validation, suggesting a strong
ssociation between these anatomic variables and
AD development. Of course, further use of the
odel in a prospective manner will be necessary to
dequately assess the accuracy of this model’s predic-
ive power. Retrospectively using the model in pa-
ients with ascending aortic enlargement prior to the
tudy date is limited by lack of widespread use of
CG-gated CTA for type B AAD. While the use of
his current model may be tempting, the model was
eveloped with retrospective data of hypertensive pa-
ients who developed AAD, and warrants prospective
alidation prior to use in a clinical setting. It may only be
ppropriate for hypertensive patients, rather than patients
ith connective tissue disorders, genetic mutations, or
ther medical conditions that develop AAD.
The central dogma with regard to AAD preven-
ion has centered upon medical therapy to control
ypertension and prevent AAD development.
nalysis of our hypertensive and AAD patients,
owever, showed no difference in the number of
atients in each group on antihypertensive medica-
ions and no difference in the number of medica-
ions being taken. Although these groups of patients
ad management of hypertension with the same
umber of antihypertensive medications, one group
ad higher systolic blood pressure and AAD.
hether or not these patients have an underlyingortopathy, more aggressive therapy may be required
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356to prevent AAD in this specific subset of patients. In
these cases, use of anatomic aortic profiles may iden-
tify those patients who require more aggressive med-
ical therapy or prophylactic surgery.
In this study, we have shown that CTA analysis
to assess length, volume, diameter, tortuosity, and
brachiocephalic angulation of the proximal aorta
provides a model that uses multiple anatomic vari-
ables to assess AAD risk. It would be tempting to
recommend CTA of all hypertensive patients were
it not for the significant burden of radiation and
cost for the many with a low risk of AAD. A more
feasible approach would be to stratify patients based
on adequacy of hypertension control. For patients
with adequate medical control, it may be feasible to
monitor ascending aortic diameters via echocardiog-
raphy, which is often part of the routine care involved
in managing hypertension. Following the ascending
aortic diameter, and altering hypertensive manage-
ment based on diameter enlargement may be a more
reasonable option for these patients. Those who show
ascending aortic diameter enlargement via echocardi-
ography despite traditional medical management may
benefit from referral for CTA and calculation of AAD
risk. Although assessment of ascending aortic diame-
ter enlargement via echocardiography provides a safe
alternative to CTA, its accuracy in diametric analysis
and AAD dissection risk have yet to be determined
and require further investigation in a prospective
manner.
Study limitations. The current study makes associa-
ions based on data obtained in a small number of
atients who had already developed AAD at the
ime of the encounter. The nature of the study led
o exclusion of a specific subset of patients with
orbidities that might have altered the geometry of
his segment, leading to a further diminution of the
lready small number of patients being studied. In
ddition, use of ECG-gated CTA for analysis
imited the sample size and study interval, as many
atients with older studies or incompatible studies
ot amenable to analysis by the vascular software
ere excluded. Despite the bootstrap technique and1:II312–7. EM, et al. The Inthat the model is influenced by characteristics unique
o the relatively small sample. Although the use of
easurements proximal to the left subclavian and
issection increase the likelihood of obtaining accurate
ortic dimensions, one cannot rule out retrograde
hanges in the proximal aorta during the 14-day
nterval deemed as acute. In addition, we cannot be
ure whether or not the blood pressure reading we
btained reflects what may have been a transient
ypertensive crisis, of unknown trigger, or is reason-
bly reflective of the usual measurements in a patient
ompliant with an ongoing blood pressure regimen.
lthough the sample size was limited by the above-
entioned factors and stepwise logistic regression is most
outinely applied to larger samples, the findings are
ertainly hypothesis generating. Characterization of an
natomic aortic profile for hypertensive patients is infor-
ative and sets the stage for prospective investigation.
C O N C L U S I O N S
Type B AAD patients are more likely to have
generalized enlargement of the proximal aorta com-
pared to patients with hypertension alone. Using
retrospective data, we have developed a multivari-
able model that uses strong associations between
aortic anatomic variables obtained from CTA and
AAD occurrence to provide a means by which to
predict AAD, warranting prospective modeling.
The presence in AAD patients of higher blood
pressures than their hypertensive counterparts without
AAD despite similar management of hypertension
suggests the presence of an underlying aortopathy in
AAD patients that require active monitoring and
aggressive management, such as serial ascending aortic
diameter measurement and multidrug antihypertensive
regimens. Using anatomical variables, we have identified
anatomic markers that may be used to identify patients
who may be at increased risk for AAD.
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